Ablation of TRIP-Br2, a regulator of fat lipolysis, thermogenesis and oxidative metabolism, prevents diet-induced obesity and insulin resistance
Chong Wee Liew(University of Illinois Chicago), Rohit Kulkarni(Joslin Diabetes Center), Cristina Mallol(Universitat Autònoma de Barcelona), Ho-Jin Koh(Joslin Diabetes Center), Dan Kawamori(Osaka City University), Dominique Langin(Université Toulouse III - Paul Sabatier), Laurie J. Goodyear(Joslin Diabetes Center), Yu‐Hua Tseng(Joslin Diabetes Center), Marc K. Hellerstein(Washington University in St. Louis), Stephen I‐Hong Hsu(University of North Carolina at Chapel Hill), Matthias Blüher(Helmholtz Centre for Environmental Research), Kristy L. Townsend(Neurological Surgery), Jit Kong Cheong(Duke-NUS Medical School), Stephen R. Farmer(Boston University), Cécile Vernochet(Groupe d'Analyse et de Théorie Economique Lyon St Etienne), Jérémie Boucher(University of Gothenburg), Jiang Hu(Joslin Diabetes Center), Alessandro Doria(Harvard University)
Cited by 79
Related Papers
Obesity: global epidemiology and pathogenesis
|Nature Reviews Endocrinology|2019|5.1k
Weight Loss with a Low-Carbohydrate, Mediterranean, or Low-Fat Diet
|New England Journal of Medicine|2008|2.1k
Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans
|Journal of Clinical Investigation|2009|1.7k
Antioxidants prevent health-promoting effects of physical exercise in humans
|Proceedings of the National Academy of Sciences|2009|1.6k
Definition and diagnostic criteria of clinical obesity
|The Lancet Diabetes & Endocrinology|2025|1.5k